OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
2.950
0.00 (0.00%)
Sep 26, 2024, 3:59 PM EDT - Market closed
OS Therapies Employees
As of December 31, 2022, OS Therapies had 4 total employees, including 3 full-time and 1 part-time employees.
Employees
4
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,637,445
Market Cap
61.82M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MDxHealth | 300 |
| Connect Biopharma Holdings | 81 |
| IO Biotech | 68 |
| Spero Therapeutics | 46 |
| Forian | 37 |
| Envoy Medical | 34 |
| Oncolytics Biotech | 29 |
| Entera Bio | 18 |
OSTX News
- 13 days ago - OS Therapies Announces Development of Two Novel Tunable Antibody Drug Conjugate (tADC)-Based Therapeutic Candidates - Business Wire
- 15 days ago - OS Therapies Announces Positive Efficacy and Safety Data for Ovarian Cancer Therapeutic Candidate Developed Based on Tunable Antibody Drug Conjugate (tADC) Platform Using Proprietary Silicone Linker Platform in Preclinical Models - Accesswire
- 21 days ago - OS Therapies to Present at H.C. Wainright 26th Annual Global Investment Conference - Business Wire
- 4 weeks ago - OS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Receives Last Treatment Dose - Business Wire
- 5 weeks ago - OS Therapies Appoints Borys Shor, PhD to ADC Advisory Board - Business Wire
- 5 weeks ago - OS Therapies Clarifies CUSIP of Common Stock - Business Wire
- 6 weeks ago - OS Therapies Reports Second Quarter 2024 Financial Results - Accesswire
- 6 weeks ago - OS Therapies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire